EAM Investors, LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 202 filers reported holding IMMUNOGEN INC in Q4 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$2,466,658
-32.1%
155,429
-19.3%
0.48%
-29.3%
Q2 2023$3,632,834
-8.0%
192,519
-48.7%
0.67%
+2.4%
Q1 2018$3,947,000
-12.7%
375,205
-36.5%
0.66%
+9.3%
Q3 2017$4,519,000
+9.0%
590,708
+1.3%
0.60%
-12.3%
Q2 2017$4,144,000582,8650.68%
Other shareholders
IMMUNOGEN INC shareholders Q4 2017
NameSharesValueWeighting ↓
QVT Financial LP 1,375,900$6,329,0001.08%
Redmile Group, LLC 12,006,979$55,232,0001.02%
Birchview Capital, LP 190,000$874,0000.53%
Fernwood Investment Management, LLC 179,340$825,0000.41%
HealthCor Management, L.P. 1,200,000$5,520,0000.23%
Grace Capital 49,500$228,0000.20%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$479,0000.19%
Virtus ETF Advisers LLC 79,795$367,0000.17%
PINNACLE ASSOCIATES LTD 1,087,034$5,000,0000.12%
HUSSMAN STRATEGIC ADVISORS, INC. 100,000$460,0000.12%
View complete list of IMMUNOGEN INC shareholders